The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells
Open accessAbstract
Oncogenes Neu/HER2/ErbB2 and Ras can induce mammary tumorigenesis via upregulation of cyclin D1. One major regulatory mechanism in these oncogenic signaling pathways is phosphorylation of serines or threonines preceding proline (pSer/Thr-Pro). Interestingly, the pSer/Thr-Pro motifs in proteins exist in two completely distinct cis and trans conformations, whose conversion is catalyzed specifically by the essential prolyl isomerase Pin1. By isomerizing pSer/Thr-Pro bonds, Pin1 can regulate the conformation and function of certain phosphorylated proteins. We have previously shown that Pin1 is overexpressed in breast tumors and positively regulates cyclin D1 by transcriptional activation and posttranslational stabilization. Moreover, in Pin1 knockout mice, mammary epithelial cells fail to undergo massive proliferation during pregnancy, as is the case in cyclin D1 null mice. These results indicate that Pin1 is upregulated in breast cancer and may be involved in mammary tumors. However, the mechanism of Pin1 overexpression in cancer and its significance in cell transformation remain largely unknown. Here we demonstrate that PIN1 expression is mediated by the transcription factor E2F and enhanced by c-Neu and Ha-Ras via E2F. Furthermore, overexpression of Pin1 not only confers transforming properties on mammary epithelial cells but also enhances the transformed phenotypes of Neu/Ras-transformed mammary epithelial cells. In contrast, inhibition of Pin1 suppresses Neu- and Ras-induced transformed phenotypes, which can be fully rescued by overexpression of a constitutively active cyclin D1 mutant that is refractory to the Pin1 inhibition. Thus, Pin1 is an E2F target gene that is essential for the Neu/Ras-induced transformation of mammary epithelial cells through activation of cyclin D1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“Various studies have revealed that Neu or Ras signaling is deregulated in many breast cancers, although mutations and amplifications of these genes were rarely observed (3, 19, 50, 54).”
BackgroundSherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 3×
“Importantly, upregulation of Pin1 has been shown to elevate cyclin D1 gene expression by activating the c-jun/AP-1 and -catenin/TCF transcription factors (44, 58).”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“GSK-3 enhances its nuclear export and subsequent degradation (2, 9 , 10).”
BackgroundSoule, H. D., Maloney, T., Wolman, S. R., Peterson, W., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., & Brooks, S. C. (1990) · PubMed · Cited by 1,507
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Sibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
Petersen, O. W., Rønnov-Jessen, L., Howlett, A. R., & Bissell, M. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9064 · Cited by 1,094
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Nevins, J. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.699 · Cited by 922
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 792
Lin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783
Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J.-U., Xu, J., Kuang, J., Kirschner, M. W., Fischer, G., et al. (1997) · Science · doi:10.1126/science.278.5345.1957 · Cited by 770
Self-citationGillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 750
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 2×
“Phosphorylation of cyclin D1 on the Thr286-Pro site by GSK-3 enhances its nuclear export and subsequent degradation (2, 9, 10).”
BackgroundThe prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Self-citationRanganathan, R., Lu, K. P., Hunter, T., & Noel, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80273-1 · Cited by 699
Self-citationMice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Function of WW Domains as Phosphoserine- or Phosphothreonine-Binding Modules
Lu, P.-J., Zhou, X. Z., Shen, M., & Lu, K. P. (1999) · Science · doi:10.1126/science.283.5406.1325 · Cited by 682
Self-citationRegulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 635
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 633
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J., & Brugge, J. S. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-785 · Cited by 554
Pin1-Dependent Prolyl Isomerization Regulates Dephosphorylation of Cdc25C and Tau Proteins
Zhou, X. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00085-x · Cited by 544
Alt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Wulf, G. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3459 · Cited by 528
Self-citationCyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Ryo, A., Nakamura, M., Wulf, G., Liou, Y.-C., & Lu, K. P. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-793 · Cited by 465
Self-citationFunction of a human cyclin gene as an oncogene.
Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., & Weinberg, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.709 · Cited by 454
Pinning down proline-directed phosphorylation signaling
Lu, K. P., Liou, Y.-C., & Zhou, X. Z. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02253-5 · Cited by 349
Self-citationLee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., Siegel, P. M., Hung, M.-C., Yarden, Y., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.672-683.2000 · Cited by 347
Shen, M., Stukenberg, P. T., Kirschner, M. W., & Lu, K. P. (1998) · Genes & Development · doi:10.1101/gad.12.5.706 · Cited by 340
Self-citationInteraction of Sp1 with the Growth- and Cell Cycle-Regulated Transcription Factor E2F
Karlseder, J., Rotheneder, H., & Wintersberger, E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1659 · Cited by 339
Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes
Liou, Y.-C., Ryo, A., Huang, H.-K., Lu, P.-J., Bronson, R., Fujimori, F., Uchida, T., Hunter, T., & Lu, K. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032404099 · Cited by 339
Self-citationA simple and rapid method for generating a deletion by PCR
Imai, Y., Matsushima, Y., Sugimura, T., & Terada, M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.10.2785 · Cited by 337
Lu, P.-J., Zhou, X. Z., Liou, Y.-C., Noel, J. P., & Lu, K. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100228200 · Cited by 244
Self-citationTarget gene specificity of E2F and pocket protein family members in living cells
Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M., & Farnham, P. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5797-5807.2000 · Cited by 229 · cited 1×
“The chromatin immunoprecipitation method was as described previously (57).”
MethodAntisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber, N., Doki, Y., Han, E. K.-H., Sgambato, A., Zhou, P., Kim, N. H., Delohery, T. M., Klein, M. G., Holt, P. R., & Weinstein, I. B. (1997) · PubMed · Cited by 226
Ras activation in human breast cancer
von Lintig, F. C., Dreilinger, A. D., Varki, N. M., Wallace, A. M., Casteel, D. E., & Boss, G. R. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006491619920 · Cited by 184
Pin1 Acts Catalytically to Promote a Conformational Change in Cdc25
Stukenberg, P. T., & Kirschner, M. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00245-3 · Cited by 169
Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism
Zhou, X. Z., Lu, P., Wulf, G. M., & Lu, K. P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050026 · Cited by 158
Self-citationKornmann, M., Arber, N., & Korc, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1323 · Cited by 155
Ohtani, K., Iwanaga, R., Nakamura, M., Ikeda, M.-A., Yabuta, N., Tsuruga, H., & Nojima, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202544 · Cited by 150
Self-citationProlyl Isomerases and Nuclear Function
Hunter, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80906-x · Cited by 117
Neill, S. D., Hemström, C., Virtanen, A., & Nevins, J. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.2008 · Cited by 107
E2F-1: a proliferative marker of breast neoplasia.
Zhang, S. Y., Liu, S. C., Al-Saleem, L. F., Holloran, D., Babb, J. S., Guo, X., & Klein–Szanto, A. J. (2000) · PubMed · Cited by 98
Invasive phenotype of MCF10A cells overexpressing c‐Ha‐ras and c‐erbB‐2 oncogenes
Giunciuglio, D., Culty, M., Fassina, G., Masiello, L., Melchiori, A., Paglialunga, G., Arand, G., Ciardiello, F., Basolo, F., Thompson, E. W., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630612 · Cited by 78
pRb and E2f-1 in mouse development and tumorigenesis
Macleod, K. F. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80005-7 · Cited by 78
K-ras modulates the cell cycle via both positive and negative regulatory pathways
Fan, J., & Bertino, J. R. (1997) · Oncogene · doi:10.1038/sj.onc.1201105 · Cited by 76
Ciardiello, F., Gottardis, M. M., Basolo, F., Pepe, S., Normanno, N., Dickson, R. B., Bianco, A. R., & Salomon, D. S. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060108 · Cited by 68
Fry, C. J., Slansky, J. E., & Farnham, P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1966 · Cited by 67
Andrechek, E. R., & Muller, W. J. (2000) · Breast Cancer Research · doi:10.1186/bcr56 · Cited by 58
Cyclin D1antisense RNA destabilizes pRb and retards lung cancer cell growth
Driscoll, B., Wu, L., Buckley, S., Hall, F. L., Anderson, K. D., & Warburton, D. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.273.5.l941 · Cited by 55
Chou, J.-L., Fan, Z., DeBlasio, T., Koff, A., Rosen, N. X., & Mendelsohn, J. M. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006217413089 · Cited by 52
Cited by
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., et al. (2011) · Nature · doi:10.1038/nature10167 · Cited by 1,030
Self-citationRetractedThe prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease
Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682
Self-citationProlyl cis-trans isomerization as a molecular timer
Lu, K. P., Finn, G., Lee, T. H., & Nicholson, L. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.35 · Cited by 652
Self-citationRyo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
Self-citationRegulation of Raf-1 by Direct Feedback Phosphorylation
Dougherty, M. K., Müller, J., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., & Morrison, D. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.055 · Cited by 633
Self-citation
Metadata
- Authors
- Ryo, A., Liou, Y.-C., Wulf, G., Nakamura, M., Lee, S. W., & Lu, K. P.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2002-08-01
- Volume
- 22
- Issue
- 15
- Pages
- 5281-5295
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2132385852
- Cited by
- 253
- References
- 61
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.